Clinical relevance of IL-6 and lactate levels within 24 hours of ICU admission of COVID-19 patients in predicting mortality rate

被引:1
|
作者
Nugroho, Andy [1 ]
Santoso, Sugeng Budi [1 ]
Permana, Septian Adi [1 ]
Hapsari, Paramita Putri [1 ]
Sitompul, Harles [1 ]
机构
[1] Sebelas Maret Univ, Dr Moewardi Gen Hosp, Dept Anesthesiol & Intens Therapy, Fac Med, Surakarta, Cent Java, Indonesia
关键词
IL-6; Lactate; ICU; COVID-19; SARS-CoV-2; CORONAVIRUS DISEASE 2019;
D O I
10.35975/apic.v26i5.2032
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
Background & objective: Patients with COVID-19 have Acute Respiratory Distress Syndrome (ARDS) which progresses to lung edema and disorders of the liver, kidneys and heart associated with cytokine storms, which are the body's immune response to SARS-CoV-2. SARS-CoV-2 patients showed clinical neutrophilia, increased D-Dimer and increased IL-6. In addition, increased lactate dehydrogenase and increased aminotransferase are often found. This study aimed to analyze the clinical relevance of increased IL-6 and lactate in the first 24 hours of ICU-admission of COVID-19 patients in predicting mortality rate. Methodology: This study was a retrospective cohort design. The study was conducted in the Intensive Care Unit (ICU) of Dr. Moewardi Surakarta Hospital. The study was conducted by tracing the medical records of COVID-19 patients treated in the ICU of Dr. Moewardi Surakarta Hospital during the period of March 1, 2020 to March 31, 2021 that met the admission criteria. The patient's mortality assessment is seen as the patient's condition for a maximum of 30 days after discharge from the hospital. Results: Variables that meet the regression model are the lactate levels (OR = 3,143; P = 0.064) as well as the IL-6 levels (OR = 25.41; p<0.001). AUC score of 86.9% with significance of < 0.001. IL-6 levels and lactate levels in the study can be used as predictors of mortality rates with 95.7% sensitivity and 60% specificity. Lactate levels in COVID-19 cases in severe cases can be related to lung damage and tissue damage. Lactate levels have also been recognized as a marker of poor prognosis in patients with COVID- 19. IL-6 as a predictor of mortality risk has been recognized and the administration of IL-6 inhibitors in COVID-19 patients may lower the risk of mortality. Conclusion: Raised IL-6 and lactate levels in this study can be a predictor of the mortality rate of COVID-19 patients within 24 hours of ICU-admission.
引用
收藏
页码:689 / 694
页数:6
相关论文
共 50 条
  • [21] Deep learning prediction of likelihood of ICU admission and mortality in COVID-19 patients using clinical variables
    Li, Xiaoran
    Ge, Peilin
    Zhu, Jocelyn
    Li, Haifang
    Graham, James
    Singer, Adam
    Richman, Paul S.
    Duong, Tim Q.
    PEERJ, 2020, 8
  • [22] Plasma IL-6 levels following corticosteroid therapy as an indicator of ICU length of stay in critically ill COVID-19 patients
    Awasthi, Samir
    Wagner, Tyler
    Venkatakrishnan, A. J.
    Puranik, Arjun
    Hurchik, Matthew
    Agarwal, Vineet
    Conrad, Ian
    Kirkup, Christian
    Arunachalam, Raman
    O'Horo, John
    Kremers, Walter
    Kashyap, Rahul
    Morice, William, II
    Halamka, John
    Williams, Amy W.
    Faubion, William A., Jr.
    Badley, Andrew D.
    Gores, Gregory J.
    Soundararajan, Venky
    CELL DEATH DISCOVERY, 2021, 7 (01)
  • [23] Plasma IL-6 levels following corticosteroid therapy as an indicator of ICU length of stay in critically ill COVID-19 patients
    Samir Awasthi
    Tyler Wagner
    A. J. Venkatakrishnan
    Arjun Puranik
    Matthew Hurchik
    Vineet Agarwal
    Ian Conrad
    Christian Kirkup
    Raman Arunachalam
    John O’Horo
    Walter Kremers
    Rahul Kashyap
    William Morice
    John Halamka
    Amy W. Williams
    William A. Faubion
    Andrew D. Badley
    Gregory J. Gores
    Venky Soundararajan
    Cell Death Discovery, 7
  • [24] Early mortality in critical illness - A descriptive analysis of patients who died within 24 hours of ICU admission
    Andersen, Sarah K.
    Montgomery, Carmel L.
    Bagshaw, Sean M.
    JOURNAL OF CRITICAL CARE, 2020, 60 : 279 - 284
  • [25] Predicting mortality rate and associated risks in COVID-19 patients
    Suneeta Satpathy
    Monika Mangla
    Nonita Sharma
    Hardik Deshmukh
    Sachinandan Mohanty
    Spatial Information Research, 2021, 29 : 455 - 464
  • [26] Predicting mortality rate and associated risks in COVID-19 patients
    Satpathy, Suneeta
    Mangla, Monika
    Sharma, Nonita
    Deshmukh, Hardik
    Mohanty, Sachinandan
    SPATIAL INFORMATION RESEARCH, 2021, 29 (04) : 455 - 464
  • [27] Correlation between premorbid IL-6 levels and COVID-19 mortality: Potential role for Vitamin D
    Silberstein, Morry
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2020, 88
  • [28] The Effect of IL-6 Inhibitors on Mortality Among Hospitalized COVID-19 Patients: A Multicenter Study
    Sinha, Pranay
    Jafarzadeh, S. Reza
    Assoumou, Sabrina A.
    Bielick, Catherine G.
    Carpenter, Bethanne
    Garg, Shivani
    Harleen, Sahni
    Neogi, Tuhina
    Nishio, Midori Jane
    Sagar, Manish
    Sharp, Veronika
    Kissin, Eugene Y.
    JOURNAL OF INFECTIOUS DISEASES, 2021, 223 (04): : 581 - 588
  • [29] Factors associated with COVID-19 inpatient mortality cases within 24 hours in South Africa
    Mphekgwana, P. M.
    Sono-Setati, M. E.
    Tshitangano, T. G.
    Matlala, S. F.
    Ramalivhana, N. J.
    SAMJ SOUTH AFRICAN MEDICAL JOURNAL, 2023, 113 (06): : 1220 - 1224
  • [30] EVALUATION OF SERUM LEVELS OF IL-6 AND ADIPONECTIN IN COVID-19 PATIENTS AND THEIR RELATIONSHIP WITH DISEASE SEVERITY
    Norouzian, M.
    Sharifi-Sarasiabi, K.
    Najafi-Asl, M.
    Azad, M. Hassani
    Babaki, H. Estabraghnia
    INFEKTSIYA I IMMUNITET, 2022, 12 (03): : 511 - 518